Request to Join
has invited you to join this group
Living in one’s own home safely and independently can improve quality of life, maintain physical health and reduce hospitalizations and healthcare costs—regardless of age, income or ability level. How can digital health or connected device solutions benefit patients living at home with chronic conditions?
Living in one’s own home safely and independently can improve quality of life, maintain physical health and reduce hospitalizations and healthcare costs—regardless of age, income or ability level....Read More
David is responsible for evolving Boston Scientific's Digital Health strategy, enabling capability building and leading the Big Data, Internet of Things (IoT), Analytics and Mobility teams.
Previously, As VP of Health IT Integration and Innovation at BD, David was responsible for the integration and development of customer facing Health IT capabilities and the identification, synthesis, development and execution of BD's solution expansion across Digital Health. David led corporate commercial Health IT development, product cybersecurity, public cloud, IoT operations and enterprise commercial alignment.
As Vice President of Corporate Strategic Innovation for Becton Dickinson (BD), David was responsible for integrating company-wide activities focused on the identification of new market opportunities outside of existing core areas, the development of high-impact growth concepts outside of, or across, existing business units and incubation of non-core offerings.
David is Chair of the Executive Council for The Center for Patient Safety Research and Practice, a thought leader in information-enabled healthcare safety. David serves as a board member and co-chair of the Digital Health Committee for the Life Science Angels, the #1 ranked angel investor group in the U.S. and for Health XL, a cross-industry consortia devoted to care transformation. With his work as a strategic advisor to several population health management companies as well as for Digital Health accelerators and incubators, David helps entrepreneurs and companies develop profitable businesses that profoundly improve healthcare quality and efficiency.
David received a Ph.D. in Mechanical Engineering from U.C. Berkeley for his work in virtual environments and medical simulation. He spent four years at medical simulator startups leading the development, commercialization and launch of state-of-the-art simulators. Prior to joining BD, David received an M.B.A. from the Harvard Business School.
Randall L. Schiestl, PMP, is the Vice President, R&D, Global Technology at Boston Scientific Corporation where he leads a team of talented R&D engineers, scientists and technicians chartered to develop and sustain a broad family of minimally invasive medical devices. Specific responsibilities include: technology management; product design; computational analysis, packaging, labeling and sterilization engineering; university relationships, new product development facilities and labs; knowledge management; and sustaining engineering. He has global responsibility for building technical community, emerging market sourcing and managing R&D information systems across BSC. His engineering teams are located across multiple facilities both US and OUS. Mr. Schiestl (Randy) has a BSME degree from the University of Minnesota, college of Science & Engineering, high distinction He also holds MBA and Executive MBA degrees from the University of Minnesota, Carlson School of Management. Randy has completed the Medical Technology Management mini-MBA at St Thomas University and is certified as a Project Management Professional. Work history includes Honeywell, Alliant Techsystems, and Boston Scientific with functional responsibilities in project and program management, product and process development, strategic planning, mergers and acquisitions, manufacturing management, supply chain, quality, information systems, test facilities, and operations. Randy serves on multiple local and national industry advisory boards and consortiums including the Medical Devices Industry Consortium, the Medical Industry Leadership Institute, Heart Advisory Committee Medical Alley, FIRST Robotics and UMN Biomedical, Medical Device Center, Nanotechnology IABs. He received the 2011 UMAA Alumni Service Award from the University of Minnesota, College of Science & Engineering and the Design of Medical Devices Conference Award in 2012.
Kate Taylor is a Global Innovation Manager at Boston Scientific, responsible for the coordination of various internal and external innovation programs across the company. Before this she was a Medical Device Innovation Fellow at the University of Minnesota in the area of digital health investigating the link between physiological markers and chronic pain with wearable sensors. She served as the VP of Engineering at Entarik leading the development of specialized feeding tubes for hospitalized patients. Kate also spent many years in Corporate R&D at Medtronic using her expertise in biomaterials, coatings and drug delivery working on a variety of medical devices including cardiac pacing, defibrillation and neuro stimulation leads, rechargeable neuro stimulators, mechanical heart valves, implantable and external drug pumps and catheters, glucose sensors and powered cutting tools.
Kate received her BS degree in Chemistry from the University of Virginia. She received her MS and PhD degrees in Materials Science and Engineering from the University of Cincinnati. Her ties with the UVA continue as a member of the Oversight Committee for the Biomedical Engineering Department's Coulter Translational Research Program.
Naeem is a renowned thought leader and author with decades of experience in designing innovative large scale high performance solutions. At Boston Scientific, Naeem advises new products architectures and design strategies; serves as data privacy and health data connectivity expert; guides analytics and data management teams to architect Digital Health/EHR connectivity platform; Prior to Boston Scientific, Naeem advised large health systems in defining digital health platforms; architected mobile PHR solutions for High Risk Pregnancy, Chronic Kidney Disease and Behavior health for population health companies. Earlier, Naeem served as Vice President, Knowledge Management & Informatics at Fresenius, where he led integration of 1800+ Dialysis Clinics; Internets and Intranets; Clinical Data Warehouses; Big Data, Business Intelligence and Informatics research initiatives. Prior to Fresenius, Naeem was Founder and Chief Research Officer for Information Frameworks. There he advised IT vendors and fortune 500 companies on innovative IT solutions/product roadmaps. Naeem specializes in Healthcare, Discrete Manufacturing, High Tech, CPG Retail/Beverage, Education and Public-sector industries. Naeem served as judge for Innovative CIO Leadership awards for CHIME, HIMSS, AHA and MIT. Naeem is a visiting faculty and founder member of Center of Knowledge Engineering at NUCES where he guides graduate students on Psyche Mining research projects. Naeem authored/coauthored for books and published hundreds of though proving articles. Naeem holds MSc in Experimental Nuclear Physics, MS in Radiological Health and Environmental Sciences specializing in engineering high-performance analytics system.
Sandra leads the Product, Platform, and Service teams within the Digital Health & Data Services organization at Boston Scientific. She is responsible for the enablement and growth of Digital Health Studio teams that incorporate innovative, user centric, agile and lean principles and practices to generate high-value and high-quality digital healthcare solutions.
Prior to joining the Digital Health & Data Services team, Sandra supported medical device development in cardiovascular, endoscopy, urology, women's health, and other therapeutics areas, helped grow innovation practices at Boston Scientific, established herself as an intrapreneur in the company, and contributed to the company's growth as a strategist in multiple areas including digital health, sensors, data analytics, imaging, diagnostics, and regenerative medicine.
Sandra is a native of Slovenia and holds a BS in Chemistry from Univerza v Ljubljani, Slovenia, an MS in Chemistry from Michigan State University, and a Ph.D. in Chemistry from Tufts University. Sandra is a past winner of multiple awards including the Boston Scientific CEO Winning Spirit Award, the John Abele Science & Technology Award, and three Boston Scientific Innovation Fund awards. Sandra has authored 26 patents and patent applications.
Bryan Clark is a Sr. R&D Manager at Boston Scientific where his current focus is on identifying and developing new solutions to solve unmet clinical needs, developing partnerships with external institutions and connecting across disciplines to drive innovation in healthcare. He has led numerous projects and partnerships across multiple technology and disease state areas including bioelectric medicine, digital health, cardiovascular disease, pulmonary disease, urological disorders, and chronic pain. He holds a Bachelor of Science in Composite Materials Engineering from Winona State University and an MBA from the Carlson School of Management at the University of Minnesota.
Jeffrey E. Stahmann received his B.S. degree in electrical engineering in 1978 and M.S. degree in electrical engineering in 1985 from the University of Wisconsin-Madison and University of Minnesota-Twin Cities respectively.
Jeffrey is a Senior Fellow in Research and Development within Boston Scientific’s Rhythm Management Division and currently leads medical science and technology exploratory activities for the division. The role comprises identification and exploration of unmet medical needs and new technology applicable to electrically active medical devices.
He has almost 30 years of experience as a development engineer and research scientist on implantable medical devices and has held multiple leadership positions. His work has concentrated on electrically active implantable devices for cardiac therapy and diagnosis including pacemakers, defibrillators, cardiac resynchronizers, implantable ECG loop recorders and pressure sensors. Prior to his career in medical devices he designed custom integrated circuits for various aerospace applications and US government agencies.
Jeffrey has been issued over 350 US patents for electrical and mechanical design, materials, sensors and algorithms relating to medical devices.
David is the inaugural Innovation Fellow at Boston Scientific from the Innovation Fellows Program through Partners Healthcare. He is embedded with the Digital Health teams under the direction of David Feygin, PhD, MBA, Chief Digital Health Officer at Boston Scientific. David works closely with the Rhythm Management team and provides clinical and scientific insights to digital health projects. Besides his role at Boston Scientific, David is also a research fellow in the lab of Calum MacRae, MD, PhD in the Cardiovascular Division at Brigham and Women’s Hospital. David obtained his BSc in Honours Physiology from the University of British Columbia in Vancouver, Canada, and his MD and PhD from Baylor College of Medicine in Houston, Texas, with a thesis focused on the molecular mechanisms of atrial fibrillation. Upon graduation David completed a post-doctoral fellowship in the lab of Albert Heck, PhD in Utrecht University, The Netherlands as a Basic Research Fellow of the European Society of Cardiology. He then came to Brigham and Women’s Hospital for his internship and residency in Internal Medicine. Upon graduation David participated in the Fellows Program at Vida Ventures in Boston and at the same time started his basic/translational research program in the MacRae Lab. Later, David joined the Partners Innovation Fellows Program and became the first Innovation Fellow at Boston Scientific. Besides his passion for basic/translational research in cardiac arrhythmias, David is also interested in working on innovative solutions for the diagnosis and management of cardiac diseases.
Carla joined the MLSC in April of 2018 as the Director of Industry Programs. In her role, she develops and manages the investment strategy for several initiatives with the life sciences industry, including private, public, and nonprofit stakeholders, in order to support the needs of the Commonwealth’s life sciences ecosystem. Prior to joining the MLSC, Carla was the recipient of a NIH F32 NRSA fellowship to support her postdoctoral research at Boston Children’s Hospital, as well as a National Science Foundation Graduate Research Fellowship Program recipient which supported her graduate research.
Most recently, as Principal, Technology Development Fund (TDF) at Boston Children’s Hospital, Carla coordinated the TDF funding cycles and proposal evaluations, served as a project manager for funded technologies, and negotiated agreements with contract research organizations and external collaborators. Carla received her Bachelor of Science in biological and agricultural engineering from Louisiana State University in Baton Rouge, LA. She earned a PhD in biomedical engineering from the Joint Department of Biomedical Engineering at North Carolina State University and the University of North Carolina at Chapel Hill. Carla has authored and co-authored 16 peer-reviewed publications in the fields of tissue engineering and wound repair.
Sarah Krüg is the CEO of CANCER101, a patient advocacy organization whose mission is to help patients and caregivers navigate the cancer journey and partner with their healthcare team to make informed decisions. Sarah is also the founder of the Health Collaboratory, a global innovations hub that paves the path for participatory co-design and collaboration in healthcare, and focused on amplifying the voice of the patient and caregiver in the design, development and continuous improvement of innovations. Through the Patient Shark Tank ®, over 16,000 patients and caregivers across disease states have evaluated over 900 innovations across the globe, including research, technology, and education. She is the Acting Executive Director and Past President of the Society for Participatory Medicine, a patient: clinician member driven organization whose mission is to enable collaborative partnerships between patients and healthcare professionals.
She previously held the position of Global Education Director in the Medical Education Group at Pfizer, as well as Patient Advocacy Relations. She also established the Global Investigator Initiated Research Program at Pfizer. Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan- Kettering Cancer Center.